返回
Virology-the path forward
DOI:10.1128/jvi.01791-23.png)
摘要
En 中文
In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.
Keyword:
COVID-19
virology
SARS-CoV-2
oversight
biosafety
emergence
期刊
IF:
3.8
论文数:
3.5W
被引数:
7.6W
机构
引用论文
Highly pathogenic avian influenza A (H5N1) in marine mammals and seabirds in Peru秘鲁海洋哺乳动物和海鸟中的高致病性禽流感A (H5N1)
NATURE COMMUNICATIONS
IF15.7
Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 20222022年10月西班牙养殖水貂的高致病性禽流感A(H5N1) 病毒感染
EUROSURVEILLANCE
IF7.8
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox
JOURNAL OF VIROLOGY
IF3.8


